Mutant KRAS and CK2 Cooperatively Stimulate SLC16A3 Activity to Drive Intrahepatic Cholangiocarcinoma Progression.
Chen R, Ma C, Qian H, Xie X, Zhang Y, Lu D, Hu S, Zhang M, Liu F, Zou Y, Gao Q, Zhou H, Liu H, Lin M, Ge G, Gao D.
Chen R, et al. Among authors: xie x.
Cancer Res. 2025 Jan 24. doi: 10.1158/0008-5472.CAN-24-2097. Online ahead of print.
Cancer Res. 2025.
PMID: 39854318